General form of registration statement for all companies including face-amount certificate companies

Consolidated Balance Sheets (Unaudited)

v2.4.0.8
Consolidated Balance Sheets (Unaudited) (USD $)
Jun. 30, 2013
Dec. 31, 2012
Dec. 31, 2011
Current assets:      
Cash $ 6,391,293 $ 2,354,169 $ 129,152
Accounts receivable 250,000     
Marketable securities - available for sale securities 6,250 12,500   
Prepaid expenses 445,925 40,333   
Assets of discontinued operations - current portion    82,145 20,000
Total current assets 7,093,468 2,489,147 149,152
Other assets:      
Property and equipment, net 8,889     
Intangible assets, net 2,501,984 492,152   
Goodwill 2,144,488     
Assets of discontinued operations - long term portion    1,035,570 3,500
Total other assets 4,655,361 1,527,722 3,500
Total Assets 11,748,829 4,016,869 152,652
Current liabilities:      
Accounts payable and accrued expenses 392,876 57,158 4,000
Notes payable - related party      152,974
Advances payable      100,000
Liabilities of discontinued operations 30,664 30,664   
Total liabilities 423,540 87,822 256,974
Stockholders' Equity:      
Preferred stock, $.0001 par value, 50,000,000 shares authorized: none issued and outstanding         
Common stock, $.0001 par value; 200,000,000 shares authorized; 5,167,988 and 3,503,565 issued and outstanding at quarters June 30, 2013 and December 31, 2012. 45,546,345 and 10,000,000 issued and outstanding at years end December 31, 2012 and 2011 517 352 1,000
Additional paid-in capital 19,794,687 10,976,325 4,000
Accumulated other comprehensive income - marketable securities available for sale (6,250)      
Deficits accumulated during the development stage (8,453,169) (7,037,134) (109,322)
Total Marathon Patent Group, Inc. equity 11,335,785 3,939,543 (104,322)
Non-controlling interest in subsidiary (10,496) (10,496)   
Total stockholders' equity 11,325,289 3,929,047 (104,322)
Total liabilities and stockholders' equity $ 11,748,829 $ 4,016,869 $ 152,652